GICD/CVRI Seminar
Monday, January 27, 2020

Steven Marx, MD

Steven O. Marx, MD, is the director of the Cardiovascular Fellowship Program at Columbia University Medical Center/NewYork-Presbyterian Hospital, and is the director of the cardiology component of an NIH training grant for cardiology fellows and surgery residents.

His research program in cardiovascular diseases at Columbia has been focused in two major areas: molecular cardiology, particularly the regulation of ion channels in normal and pathological conditions in the heart, and vascular biology, particularly the molecular mechanisms of vascular smooth muscle proliferation, migration, and contractility. Working with others at Columbia, Marx has identified rapamycin (sirolimus) as a therapeutic agent for preventing restenosis after angioplasty/stent implantation. He also characterized the dysfunction of the ryanodine receptor in heart failure. A major focus of Marx’s current research is the regulation of arterial contractility and blood pressure by the ion channels.

Details

Date
January 27, 2020
Time
3:00-4:00pm PST
Location
Mahley Auditorium
Audience
Scientific

The GICD/CVRI Seminar series is a collaborative series between the Gladstone Institute of Cardiovascular Disease and the Cardiovascular Research Institute at UC San Francisco.

Diversity, Equity, and Inclusion

At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.

We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.